A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Neurosciences Bookmark and Share

Neurosciences

Study of the nervous system has a long tradition at City of Hope, which was one of the first institutions in North America to establish a neurobiology research department.

The Department of Neurosciences offers a multidisciplinary research and training environment in neurobiology, with a particular focus on developmental aspects of the nervous system. Research in the department encompasses molecular and cellular neurobiology, genetics and neurophysiology, with ongoing studies in neurogenesis and synaptogenesis, migration and specification, degeneration and embryonic stem cell differentiation.

Researchers in the department collaborate with colleagues in other basic science departments and divisions as well as clinical researchers in neuro-oncology programs, focusing on cancer immunotherapy and neurosurgery.
 
Laboratory Research
The Department of Neurosciences spans a broad range of research interests; grouped into three major categories:

I.Several investigators are interested in the earliest periods of neurogenesis and lineage commitment, and are examining stem and progenitor cells in developing and mature brain:
 
  • Qiang Lu, Ph.D. – Neural Progenitor/Stem Cells in Brain Development
    Dr. Lu’s research is concerned with intercellular signaling by ephrins and Eph receptors and their regulation of neuronal birth and migration during early development of the cerebral cortex.
 
  • Yanhong Shi, Ph.D. – Nuclear Receptors in Neural Stem Cells and Adult Neurogenesis
    Dr. Shi is studying the nuclear receptors that control generation and differentiation of neural lineage stem cells in the adult nervous system.
 
  • Michael Barish, Ph.D. – Neurobiology of Development
    Dr. Barish is investigating early electrical activity in the developing hippocampus and cortex and its relationship to neural birth, migration and maturation.
     
  • Karen S. Aboody, M.D.Translational Research
    Dr. Aboody oversees a translational research laboratory focused on neural stem cells (NSCs) as a platform for targeted delivery of therapeutic agents to invasive and metastatic solid tumors.

II.Several faculty have research foci in neural specification, processes that impart individuality to developing neurons, and in the functioning of mature neurons.
 
  • Paul Salvaterra, Ph.D. – Molecular Neurobiology
    Dr. Salvaterra’s research is focused on the regulation of transmitter phenotype, how gene expression is coordinated to allow synthesis and release of individual neurotransmitters.
 
  • Toshifumi Tomoda, Ph.D. – Axonal Trafficking / Neurodegeneration
    Dr. Tomoda is interested in membrane transport and cycling, and its role in axon and dendrite growth, differentiation of synapses, and stress-induced autophagy.
 
  • Kazuo Ikeda, Ph.D. – Neurophysiology
    Dr. Ikeda studies the mechanisms of synaptic transmission and plasticity, focusing on endocytosis of synaptic vesicle membrane from presynaptic terminals and processes of recovery from vesicle depletion as a consequence of activity.

III.Several faculty members also have projects that relate their fundamental research interests to mechanisms underlying diseases of the human nervous system.
 
  • Dr. Salvaterra is developing Drosophila models for Alzheimer’s and other degenerative diseases.
     
  • Dr. Lu is examining how alteration in the neural stem cell decision to proliferate or differentiate controlled by ephrin/Eph receptor signaling may be involved in the earliest stages of tumorigenesis.
     
  • Dr. Tomoda is investigating possible connections between genes involved in membrane cycling and autophagy, and several diseases including Huntington’s and schizophrenia.
     
  • Dr. Barish, in collaboration with Karen Aboody, M.D. , (Hematology/HCT) and Carlotta Glackin, Ph.D. , is examining the molecular mechanisms of neural progenitor cell migration to glioma and tumors outside the brain, and targeting of these tumors with genetically-modified therapeutics using immortalized neural progenitor cells.
     
  • Dr. Glackin and her laboratory are investigating the molecular mechanisms of a bHLH transcription factor, TWIST, in regulating cellular invasiveness. Understanding these mechanisms has allowed her laboratory to develop novel genetically-modified therapeutics that interferes with TWIST function to competitively inhibit cellular invasion of tumor cells.

Neurosciences Faculty

Neurosciences

Neurosciences

Study of the nervous system has a long tradition at City of Hope, which was one of the first institutions in North America to establish a neurobiology research department.

The Department of Neurosciences offers a multidisciplinary research and training environment in neurobiology, with a particular focus on developmental aspects of the nervous system. Research in the department encompasses molecular and cellular neurobiology, genetics and neurophysiology, with ongoing studies in neurogenesis and synaptogenesis, migration and specification, degeneration and embryonic stem cell differentiation.

Researchers in the department collaborate with colleagues in other basic science departments and divisions as well as clinical researchers in neuro-oncology programs, focusing on cancer immunotherapy and neurosurgery.
 
Laboratory Research
The Department of Neurosciences spans a broad range of research interests; grouped into three major categories:

I.Several investigators are interested in the earliest periods of neurogenesis and lineage commitment, and are examining stem and progenitor cells in developing and mature brain:
 
  • Qiang Lu, Ph.D. – Neural Progenitor/Stem Cells in Brain Development
    Dr. Lu’s research is concerned with intercellular signaling by ephrins and Eph receptors and their regulation of neuronal birth and migration during early development of the cerebral cortex.
 
  • Yanhong Shi, Ph.D. – Nuclear Receptors in Neural Stem Cells and Adult Neurogenesis
    Dr. Shi is studying the nuclear receptors that control generation and differentiation of neural lineage stem cells in the adult nervous system.
 
  • Michael Barish, Ph.D. – Neurobiology of Development
    Dr. Barish is investigating early electrical activity in the developing hippocampus and cortex and its relationship to neural birth, migration and maturation.
     
  • Karen S. Aboody, M.D.Translational Research
    Dr. Aboody oversees a translational research laboratory focused on neural stem cells (NSCs) as a platform for targeted delivery of therapeutic agents to invasive and metastatic solid tumors.

II.Several faculty have research foci in neural specification, processes that impart individuality to developing neurons, and in the functioning of mature neurons.
 
  • Paul Salvaterra, Ph.D. – Molecular Neurobiology
    Dr. Salvaterra’s research is focused on the regulation of transmitter phenotype, how gene expression is coordinated to allow synthesis and release of individual neurotransmitters.
 
  • Toshifumi Tomoda, Ph.D. – Axonal Trafficking / Neurodegeneration
    Dr. Tomoda is interested in membrane transport and cycling, and its role in axon and dendrite growth, differentiation of synapses, and stress-induced autophagy.
 
  • Kazuo Ikeda, Ph.D. – Neurophysiology
    Dr. Ikeda studies the mechanisms of synaptic transmission and plasticity, focusing on endocytosis of synaptic vesicle membrane from presynaptic terminals and processes of recovery from vesicle depletion as a consequence of activity.

III.Several faculty members also have projects that relate their fundamental research interests to mechanisms underlying diseases of the human nervous system.
 
  • Dr. Salvaterra is developing Drosophila models for Alzheimer’s and other degenerative diseases.
     
  • Dr. Lu is examining how alteration in the neural stem cell decision to proliferate or differentiate controlled by ephrin/Eph receptor signaling may be involved in the earliest stages of tumorigenesis.
     
  • Dr. Tomoda is investigating possible connections between genes involved in membrane cycling and autophagy, and several diseases including Huntington’s and schizophrenia.
     
  • Dr. Barish, in collaboration with Karen Aboody, M.D. , (Hematology/HCT) and Carlotta Glackin, Ph.D. , is examining the molecular mechanisms of neural progenitor cell migration to glioma and tumors outside the brain, and targeting of these tumors with genetically-modified therapeutics using immortalized neural progenitor cells.
     
  • Dr. Glackin and her laboratory are investigating the molecular mechanisms of a bHLH transcription factor, TWIST, in regulating cellular invasiveness. Understanding these mechanisms has allowed her laboratory to develop novel genetically-modified therapeutics that interferes with TWIST function to competitively inhibit cellular invasion of tumor cells.

Neurosciences Faculty

Neurosciences Faculty

Overview
Beckman Research Institute of City of Hope is responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
 
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 


NEWS & UPDATES
  • Valentine’s Day is synonymous with dinner reservations, red roses, heart-shaped boxes of chocolates and — more often than not — unrealistically high expectations. Managing those expectations is great advice for all couples on Feb. 14 — and is especially important for couples confronting a cancer diagnosis. Focu...
  • With measles, what starts at a theme park in California definitely doesn’t stay at a theme park in California. Since the beginning of the current measles outbreak – traced to an initial exposure at Disneyland or Disney California Adventure during December – more than 100 people have been diagnosed with a diseas...
  • Even the most loving and secure relationship can be rattled by a life-threatening illness. When a woman is diagnosed with breast cancer, research shows one of the most important factors in helping her cope is having a supportive partner. But that partner can struggle with knowing what to say or how to best supp...
  • It’s been more than a century since Nobel Laureate Paul Ehrlich popularized the idea of a “magic bullet” targeting disease. Cancer researchers ever since have remained in hot pursuit of targeted therapies that home in on cancer cells while leaving normal cells unaffected. Linda Malkas, Ph.D., associate chair of...
  • Cancer patients face a daunting journey marked by challenges and uncertainties. For those undergoing bone marrow, or stem cell, transplantation, one complication poses a particular threat — chronic graft-versus-host disease (GVHD). Now, one researcher may have found a better way to control that threat. GVHD res...
  • Michele Dahlstein, a 50-year-old breast cancer survivor from Upland, California, celebrated her last day of chemotherapy on Dec. 30. She shares her story in her own words: I was diagnosed with breast cancer (invasive ductal carcinoma stage 2) on Aug. 11, 2014, after my yearly mammogram at City of Hope’s W...
  • The treatment of urologic cancers, including bladder cancer, is rapidly evolving. Here, urologic oncologic surgeon and kidney stone specialist Donald Hannoun, M.D., an assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope | Antelope Valley, explains the changes in hi...
  • A woman confronting metastatic breast cancer faces challenges that, at the outset, seem overwhelming. Research tells us these patients are especially vulnerable to anxiety, depression, hopelessness and other sources of distress. At the same time, they are asked to make complicated choices about their medical ca...
  • California health officials are opting to be safe rather than sorry when it comes to e-cigarettes. The increasingly popular devices are a public health threat, according to a California Department of Health report released Jan. 28. The department is seeking statewide regulation of e-cigarettes, saying they  emi...
  • “Not beyond us.” On World Cancer Day, researchers and caregivers around the globe are embracing this refrain. Specifically, the day calls for action to support healthier lifestyles, early cancer detection, quality of life and access to care. In a time of impressive scientific discovery and narrowing...
  • With more advanced cancer treatments and therapies saving lives every day, it’s safe to say cancer is “Not beyond us,” the official tagline for this year’s World Cancer Day. This year’s World Cancer Day observance takes place on Wednesday, Feb. 4, and focuses on cancer prevention, detection an...
  • Does our environment increase our risk of cancer? What about plastic bottles, radiation, chemicals, soy products …? Do they cause cancer? With so many cancer fears, rumors and downright urban legends circulating among our friends and colleagues, not to mention in the media and blogosphere, why not ask the...
  • With this week’s World Cancer Day challenging us to think about cancer on a global scale, we should also keep in mind that daily choices affect cancer risk on an individual scale. Simply put, lifestyle changes and everyday actions can reduce your cancer risk and perhaps prevent some cancers. According to ...
  • If you haven’t heard the term “precision medicine,” you will. If you don’t have an opinion about access to it, you will. On Friday, President Barack Obama unveiled details of the Precision Medicine Initiative, an effort intended to accelerate cancer research in a powerful way, giving doctors new knowledge and n...
  • The lack of a practical way to produce and store enough stem cells for larger-scale therapies and clinical trials is creating a bottleneck in stem cell research. A new grant to City of Hope from the California Institute for Regenerative Medicine (CIRM) will help solve that problem. The $899,728 grant, awarded T...